Your browser doesn't support javascript.
loading
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
Sunada, Shigeaki; Saito, Hiroko; Zhang, Doudou; Xu, Zeyu; Miki, Yoshio.
Afiliação
  • Sunada S; Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: sunada.mgen@mri.tmd.ac.jp.
  • Saito H; Department of Genetic Diagnosis, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Zhang D; Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
  • Xu Z; Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
  • Miki Y; Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; Department of Genetic Diagnosis, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: miki.mgen@mri.tmd.ac.jp.
Biochem Biophys Res Commun ; 550: 56-61, 2021 04 23.
Article em En | MEDLINE | ID: mdl-33684621

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Divisão Celular / Proteína Quinase CDC2 / Inibidores de Proteínas Quinases / Pontos de Checagem da Fase G2 do Ciclo Celular Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Divisão Celular / Proteína Quinase CDC2 / Inibidores de Proteínas Quinases / Pontos de Checagem da Fase G2 do Ciclo Celular Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article